Blanchard, S. K., Sullivan, K. M., Hooten, J. N., Holcomb, Z. E., Rowe Nichols, K., Selim, M. A., … Cardones, A. R. (2019). High-dose intravenous immunoglobulin as adjuvant treatment for grade IV acute cutaneous graft-versus-host disease. Br J Dermatol, 181(4), 869–871. https://doi.org/10.1111/bjd.18028

Blanchard, S. K., K. M. Sullivan, J. N. Hooten, Z. E. Holcomb, K. Rowe Nichols, M. A. Selim, C. L. Rao, R. P. Hall, N. J. Chao, and A. R. Cardones. “High-dose intravenous immunoglobulin as adjuvant treatment for grade IV acute cutaneous graft-versus-host disease.” Br J Dermatol 181, no. 4 (October 2019): 869–71. https://doi.org/10.1111/bjd.18028.

Blanchard SK, Sullivan KM, Hooten JN, Holcomb ZE, Rowe Nichols K, Selim MA, et al. High-dose intravenous immunoglobulin as adjuvant treatment for grade IV acute cutaneous graft-versus-host disease. Br J Dermatol. 2019 Oct;181(4):869–71.

Blanchard, S. K., et al. “High-dose intravenous immunoglobulin as adjuvant treatment for grade IV acute cutaneous graft-versus-host disease.” Br J Dermatol, vol. 181, no. 4, Oct. 2019, pp. 869–71. Pubmed, doi:10.1111/bjd.18028.

Blanchard SK, Sullivan KM, Hooten JN, Holcomb ZE, Rowe Nichols K, Selim MA, Rao CL, Hall RP, Chao NJ, Cardones AR. High-dose intravenous immunoglobulin as adjuvant treatment for grade IV acute cutaneous graft-versus-host disease. Br J Dermatol. 2019 Oct;181(4):869–871.